🔥🐔 BizChicken 🐔🔥
Companies Similar to Tourmaline Bio, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Disc Medicine, Inc.
Therapeutic candidates for hematologic diseases
Disc Medicine, Inc. is a clinical-stage biotechnology company focused on discovering, developing, and commercializing novel treatments for patients with serious hematologic diseases. The company's portfolio addresses hematologic diseases by targeting key biological pathways in red blood cell biology.
Symbol: IRON
Recent Price: $61.60
Industry: Biotechnology
CEO: Dr. John D. Quisel Esq., J.D., Ph.D.
Sector: Healthcare
Employees: 78
Address: 321 Arsenal Street, Watertown, MA 02472
Phone: 617 674 9274
Last updated: 2024-12-31
INmune Bio, Inc.
INKmune
INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.
Symbol: INMB
Recent Price: $4.65
Industry: Biotechnology
CEO: Dr. Raymond Joseph Tesi M.D.
Sector: Healthcare
Employees: 11
Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432
Phone: 858 964 3720
Last updated: 2024-12-31
Telomir Pharmaceuticals, Inc. Common Stock
TELOMIR-1
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on developing and commercializing therapies for age-related inflammatory conditions and post-chemotherapy recovery.
Symbol: TELO
Recent Price: $4.64
Industry: Biotechnology
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 1
Address: 855 N Wolfe Street, Baltimore, null 21205
Phone: (737)-289-0835
Last updated: 2024-12-31
Tourmaline Bio, Inc.
medicines for immune diseases
Tourmaline Bio, Inc. is a clinical biotechnology company focused on developing medicines for patients with life-altering immune diseases, such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).
Symbol: TRML
Recent Price: $20.08
Industry: Biotechnology
CEO: Dr. Sandeep C. Kulkarni M.D.
Sector: Healthcare
Employees: 70
Address: 27 West 24th Street, New York, NY 10010
Phone: 646-481-9832
Last updated: 2024-12-31
Travere Therapeutics, Inc.
Chenodal, Cholbam, Thiola, Sparsentan, TVT-058
Travere Therapeutics, Inc. is a biopharmaceutical company that focuses on identifying, developing, commercializing, and delivering therapies for the treatment of rare diseases. Its products include Chenodal, Cholbam, Thiola, and candidates like Sparsentan and TVT-058.
About | Leadership | About | About | About | Contact | Contact | Careers | Careers | About | News | About | About | About | About | About | About | News | Events | About | About | ESG | About | Jobs | Jobs | Careers | About | About | About | About
Symbol: TVTX
Recent Price: $17.32
Industry: Biotechnology
CEO: Dr. Eric M. Dube Ph.D.
Sector: Healthcare
Employees: 380
Address: 3611 Valley Centre Drive, San Diego, CA 92130
Phone: 888 969 7879
Leadership
- Eric Dube, Ph.D., President & Chief Executive Officer
- Chris Cline, CFA, Chief Financial Officer
- Angela Giannantonio, Senior Vice President, Human Resources
- Peter Heerma, Chief Commercial Officer
- Jula Inrig, M.D., Chief Medical Officer
- Casey Logan, Chief Business Officer
- Elizabeth Reed, J.D., Senior Vice President, General Counsel, Corporate Secretary
- William Rote, Ph.D., Senior Vice President, Research & Development
- Charlotte Smith, Senior Vice President, Public Affairs
- Gary A. Lyons, Chairman
- Roy D. Baynes, M.D., Ph.D.,
- Suzanne L. Bruhn, Ph.D.,
- Tim Coughlin, CPA,
- Jeffrey A. Meckler,
- John A. Orwin,
- Sandra E. Poole,
- Ron Squarer,
- Ruth Williams-Brinkley, FACHE,
Last updated: 2024-12-31
Atara Biotherapeutics, Inc.
T-cell immunotherapy treatments
Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.
About | About | About | Contact | About | Careers | Careers | About | Careers | Careers | About | About
Symbol: ATRA
Recent Price: $13.28
Industry: Biotechnology
CEO: Dr. Anhco Nguyen Ph.D.
Sector: Healthcare
Employees: 165
Address: 611 Gateway Boulevard, South San Francisco, CA 94080
Phone: 650 278 8930
Last updated: 2024-12-31
Black Diamond Therapeutics, Inc.
BDTX-189, BDTX-1535, BDTX-4933
Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.
Symbol: BDTX
Recent Price: $2.15
Industry: Biotechnology
CEO: Dr. Mark A. Velleca M.D., Ph.D.
Sector: Healthcare
Employees: 54
Address: One Main Street, Cambridge, MA 02142
Phone: 617 252 0848
Leadership
- Ali Behbahani, M.D., Co-Head of Healthcare, NEA
- Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
- Kapil Dhingra, M.D., Former Head, Roche Oncology Development
- Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
- Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
- Prakash Raman, Ph.D., CEO of InduPro, Inc.
- Mark A. Velleca, M.D., Ph.D., CEO and Board Chair
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
Gritstone bio, Inc.
GRANITE
Gritstone bio, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and infectious diseases, with lead products including GRANITE, SLATE, and CORAL.
Symbol: GRTS
Recent Price: $0.03
Industry: Biotechnology
CEO: Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Sector: Healthcare
Employees: 231
Address: 5959 Horton Street, EmeryVille, CA 94608
Phone: 510 871 6100
Last updated: 2024-12-31
Immunome, Inc.
IMM-ONC-01, IMM-BCP-01
Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.
Symbol: IMNM
Recent Price: $10.28
Industry: Biotechnology
CEO: Dr. Clay B. Siegall Ph.D.
Sector: Healthcare
Employees: 78
Address: 665 Stockton Drive, Exton, PA 19341
Phone: 610 321 3700
Last updated: 2024-12-31
Indaptus Therapeutics, Inc.
Decoy20
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company focusing on the development of anti-cancer and anti-viral immunotherapy products, with its lead clinical candidate, Decoy20, targeting lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as viral infections.
Symbol: INDP
Recent Price: $0.87
Industry: Biotechnology
CEO: Mr. Jeffrey A. Meckler
Sector: Healthcare
Employees: 7
Address: 3 Columbus Circle, New York, NY 10019
Phone: 347 480 9760
Last updated: 2024-12-31
NexImmune, Inc.
Artificial Immune Modulation
Nex Immune, Inc., a clinical-stage biotechnology company, develops therapies for cancer and immune-mediated diseases using its Artificial Immune Modulation platform. The company is advancing cell therapy candidates including NEXI-001, NEXI-002, and NEXI-003.
About | Leadership | About | About | About | About | Leadership | About | About | Contact | Contact | Contact | Careers | Careers | About | About | About | About
Symbol: NEXI
Recent Price: $0.15
Industry: Biotechnology
CEO: Mr. John Trainer M.B.A.
Sector: Healthcare
Employees: 6
Address: 9119 Gaither Road, Gaithersburg, MD 20877
Phone: 301 825 9810
Leadership
- Kristi Jones, Chief Executive Officer
- Mathias Oelke, Ph.D., Chief Scientific Officer
- Daniel Bednarik Ph.D., Senior Vice President, Molecular Engineering & Protein Design
- Jack Ragheb, Senior Vice President, Translational Science
- Tonya Catterton, Vice President, Quality & Compliance
- Tim Stover, Vice President, Corporate Controller
- Karen Haslbeck, Head, Human Resources
- Matt Schiller, Head, Business Development
Last updated: 2024-12-31
Cartesian Therapeutics, Inc.
SEL-302, SEL-212
Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing nanoparticle immunomodulatory drugs for treating and preventing human diseases. The company has various programs including gene therapies and biologic therapies for conditions like methylmalonic acidemia and chronic refractory gout.
Symbol: RNAC
Recent Price: $18.76
Industry: Biotechnology
CEO: Dr. Carsten Brunn Ph.D.
Sector: Healthcare
Employees: 37
Address: 65 Grove Street, Watertown, MA 02472
Phone: 617 923 1400
Last updated: 2024-12-31
TG Therapeutics, Inc.
Ublituximab, Umbralisib, Cosibelimab, TG-1701, TG-1801
TG Therapeutics, Inc. is a commercial stage biopharmaceutical company focused on developing and commercializing novel treatments for B-cell malignancies and autoimmune diseases.
About | About | Leadership | About | About | About | About | Our Story | Contact | Contact | About | About
Symbol: TGTX
Recent Price: $31.45
Industry: Biotechnology
CEO: Mr. Michael S. Weiss Esq.
Sector: Healthcare
Employees: 264
Address: 2 Gansevoort Street, New York, NY 10014
Phone: 212 554 4484
Leadership
- Michael S. Weiss, Chairman, President, and Chief Executive Officer
- Sean A. Power, CPA, Chief Financial Officer
- Adam Waldman, Chief Commercialization Officer
Last updated: 2024-12-31
Third Harmonic Bio, Inc.
THB001
Third Harmonic Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing medicine for allergic and inflammatory diseases, including THB001, an oral small-molecule KIT inhibitor for treating chronic urticaria and other indications.
Symbol: THRD
Recent Price: $10.38
Industry: Biotechnology
CEO: Ms. Natalie C. Holles
Sector: Healthcare
Employees: 42
Address: 300 Technology Square, Cambridge, MA 02139
Phone: 617-915-6680
Last updated: 2024-12-31
Turnstone Biologics Corp.
TIDAL-01
Turnstone Biologics Corp. is a clinical stage biotechnology company focused on developing medicines for treating and curing patients with solid tumors. Its lead product, TIDAL-01, is in Phase 1 clinical trials for various cancers.
About | About | About | About | About | About | About | About | About | About | About | About
Symbol: TSBX
Recent Price: $0.50
Industry: Biotechnology
CEO: Dr. Sammy J. Farah M.B.A., Ph.D.
Sector: Healthcare
Employees: 82
Address: 9310 Athena Circle, LA Jolla, CA 92037
Phone: 347-897-5988
Last updated: 2024-12-31
Adaptive Biotechnologies Corporation
immunoSEQ
Adaptive Biotechnologies Corporation is a commercial-stage company that develops an immune medicine platform for diagnosing and treating various diseases, including COVID-19 and lymphoid cancers.
Leadership | Contact | About | About | About | About | Careers | Careers | About | About | About | About | About
Symbol: ADPT
Recent Price: $6.11
Industry: Biotechnology
CEO: Mr. Chad M. Robins M.B.A.
Sector: Healthcare
Employees: 709
Address: 1165 Eastlake Avenue East, Seattle, WA 98109
Phone: 206 659 0067
Last updated: 2024-12-31
Tango Therapeutics, Inc.
TNG908
Tango Therapeutics, Inc. is a biotechnology company focused on discovering and developing drugs for cancer treatment, with a lead program TNG908 targeting cancers with methylthioadenosine phosphorylase deletions. The company also works on therapies for BRCA1/2-mutant and STK11-mutant cancers and collaborates with Gilead Sciences, Inc.
Symbol: TNGX
Recent Price: $3.10
Industry: Biotechnology
CEO: Dr. Barbara L. Weber M.D.
Sector: Healthcare
Employees: 140
Address: 100 Binney Street, Cambridge, MA 02142
Phone: 857 320 4900
Last updated: 2024-12-31
Ventyx Biosciences, Inc.
VTX958
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.
Symbol: VTYX
Recent Price: $2.23
Industry: Biotechnology
CEO: Dr. Raju S. Mohan Ph.D.
Sector: Healthcare
Employees: 73
Address: 662 Encinitas Boulevard, Encinitas, CA 92024
Phone: 760 593 4832
Last updated: 2024-12-31